U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231705) titled 'Growth and Tolerance of Plant-based Enteral Formulas in Children Ages 12-17 Months.' on Nov. 13.
Brief Summary: The purpose of this prospective study is to evaluate the growth and enteral tolerance of two pea protein-based formulas from Kate Farms in children aged 12 to 17 months who are expected to meet most of their nutritional needs through formula. It is hypothesized that the Pediatric Standard 1.2 and Pediatric Peptide 1.0 formulas will support healthy growth in children between 1 and 2 years of age. The study will assess the impact of these formulas on growth, tolerance, body composition, micronutrient levels, and gut microbio...